Page 40 - Journal of Structural Heart Disease Volume 2, Issue 1

Original Research Article
34
fracture, valve dysfunction, and right ventricular out ow tract reintervention after transcatheter pulmonary valve im- plantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circulation. Cardiovascular interventions 2011;4(6):602-614. DOI: 10.1161/CIRCIN- TERVENTIONS.111.965616
5. Feltes TF, Bacha E, Beekman RH 3rd, Cheatham JP, Feinstein JA, Gomes AS, et al. American Heart Association Congen- ital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; American Heart Association. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scienti c statement from the American Heart Association. Circulation. 2011;7;123(22):2607-2652. DOI: 10.1161/ CIR.0b013e31821b1f10
6. Bosho DE, Cools BL, Heying R, Troost
E, Kefer J, Budts W, et al. O -label use of percutaneous pulmonary valved stents
in the right ventricular out ow tract: time to rewrite the label? Catheterization and cardiovascular interventions : o cial jour- nal of the Society for Cardiac Angiography
& Interventions 2013;81(6):987-995. DOI:
10.1002/ccd.24594
7. Gillespie MJ, Rome JJ, Levi DS, Williams RJ, Rhodes JF, Cheatham JP, et al. Melody valve implant within failed bioprosthet- ic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5(6):862-870. DOI: 10.1161/ CIRCINTERVENTIONS.112.972216
8. Meadows JJ, Moore PM, Berman DP, Cheatham JP, Cheatham SL, Porras D, et al. Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular out ow tracts. Circ Cardiovasc Interv. 2014;7(3):374-380. DOI: 10.1161/ CIRCINTERVENTIONS.114.001225
9. Morray BH, McElhinney DB, Cheatham JP, Zahn EM, Berman DP, Sullivan PM, et al. Risk of coronary artery compression among patients referred for transcath- eter pulmonary valve implantation: a multicenter experience. Circulation. Car- diovascular interventions 2013;6(5):535- 542. DOI: 10.1161/CIRCINTERVEN- TIONS.113.000202
10. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, et al. Risk strati cation, systematic classi cation,
11.
12.
and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 2007;115(11):1392-1397. DOI: 10.1161/ CIRCULATIONAHA.106.674259
Cools B, Budts W, Heying R, Bosho D, Eyskens B, Frerich S, Troost E, Gewillig M. Medium term follow-up after percuta- neous pulmonary valve replacement with the Melody® valve. IJC Heart & Vasculature 2015;7:92–97. DOI: 10.1016/j. ijcha.2015.02.014
Van Dijck I, Budts W, Cools B, Eyskens B, Bosho DE , Heying R, et al. Infective endocarditis of the Melody valved stent in comparison to surgical implants in Right Ventricular Out ow Tract. Heart. 2015;101(10):788-93. DOI: 10.1136/heart- jnl-2014-306761
Journal of Structural Heart Disease, February 2016
Volume 2, Issue 1: 33-34
Cite this article as: Gewillig M. Current Status of Percutaneous Pulmonic Valve Therapies: The Melody Valve. Journal of Structural Heart Disease 2015;1(2):33- 34. DOI: http://dx.doi.org/10.12945/j. jshd.2015.012.14